Olga Oleshko

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Platelets link coagulation and complement in regulating murine placental vascular development.

Platelets link coagulation and complement in regulating murine placental vascular development.

Journal: The Journal of clinical investigation

Published: July 23, 2026

Transfer of Emicizumab into Breast Milk in Postpartum Acquired Hemophilia A.

Transfer of Emicizumab into Breast Milk in Postpartum Acquired Hemophilia A.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 09, 2026

Pharmacodynamic Interaction Between Emicizumab and Coagulation Factor VIII.

Pharmacodynamic Interaction Between Emicizumab and Coagulation Factor VIII.

Journal: Thrombosis and haemostasis

Published: February 03, 2026

Laboratory Monitoring in Patients Receiving Emicizumab.

Laboratory Monitoring in Patients Receiving Emicizumab.

Journal: Hamostaseologie

Published: October 09, 2025

Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins.

Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins.

Journal: Research and practice in thrombosis and haemostasis

Published: July 27, 2025

Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxis.

Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxis.

Journal: Haematologica

Published: April 24, 2025

von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.

von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.

Journal: Blood advances

Published: April 05, 2023

Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study.

Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study.

Journal: Blood advances

Published: May 12, 2022

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.

Journal: Blood

Published: April 17, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026